Skip to main content

Table 2 Angiographic features and procedural details

From: Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis

 

Normal UA

(n = 257)

Higher UA

(n = 71)

p-value

Previous PCI characteristics

Stent type

 BMS, n (%)

21 (8.3)

5 (7.5)

 

 1st generation DES, n (%)

88 (34.9)

35 (52.2)

0.075

 2nd generation DES, n (%)

108 (42.9)

21 (31.3)

 

 3rd generation DES, n (%)

35 (13.9)

6 (9.0)

 

Stent diameter (mm)

2.9 ± 0.3

2.9 ± 0.3

0.900

Stent length (mm)

22.7 ± 7.2

22.0 ± 7.5

0.504

Median duration between previous PCI to the index procedure (day)

990

1669

0.045

Lesion characteristics at the index PCI

Target vessel, n (%)

 LAD

166 (64.6)

49 (69.0)

0.478

 LCX

40 (15.6)

7 (9.9)

 

 RCA

51 (19.8)

15 (21.1)

 

Multivessel involvement, n (%)

166 (64.6)

53 (74.6)

0.147

CTO, n (%)

17 (6.6)

7 (9.9)

0.502

ISR type (II, III, IV), n (%)

95 (37.0)

38 (53.5)

0.017

Procedures of the index PCI

PCI type

 DES

174 (67.7)

52 (73.2)

0.455

 DCB

83 (32.3)

19 (26.8)

 

DES type

 1st generation DES, n (%)

17 (9.8)

7 (13.5)

0.354

 2nd generation DES, n (%)

116 (66.7)

29 (55.8)

 

 3rd generation DES, n (%)

41 (23.6)

16 (30.8)

 

DES diameter (mm)

2.9 ± 0.4

3.0 ± 0.5

0.010

DES length (mm)

23.1 ± 11.5

23.8 ± 10.3

0.685

DCB diameter (mm)

2.8 ± 0.3

2.9 ± 0.3

0.344

DCB length (mm)

20.2 ± 5.2

20.0 ± 5.1

0.875

  1. Data were presented as n (%) or mean ± SD. PCI, percutaneous coronary intervention; BMS, bare metal stent; DES, drug-eluting stent; LAD, left anterior descending artery; LCX, left circumflex artery; RCA right coronary artery; CTO, chronic total occlusion; ISR, in-stent restenosis; DCB, drug-coated balloon